Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|May 31, 2006
10th anniversary Inflammation and Immune Diseases Drug Discovery and Development Summit. 20-21 March 2006, New Brunswick, USAMartin Braddock, Clare MurrayThe New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body|September 28, 2019
Why Human Enhancement is Necessary for Successful Human Deep-space MissionsKonrad Szocik, Martin BraddockExpert Opinion on Biological Therapy|June 4, 2004
Therapeutic potential of targeting IL-1 and IL-18 in inflammationMartin Braddock, Anthony Quinn, Jan CanvinExpert Opinion on Drug Safety|May 9, 2013
Cardiovascular safety and hemodynamic considerations in oncology drug development - webinar highlights October 10th 2012Martin Braddock, Jeff Heilbraun, Boaz MendzelevskiClinical and Experimental Rheumatology|October 8, 2014
Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonismIain B McInnes, Simon Cruwys, Keith Bowers, et al.Cytotherapy|January 8, 2010
Liver tissue engineering: promises and prospects of new technologyMing-Hua Zheng, Chao Ye, Martin Braddock, et al.Expert Opinion on Investigational Drugs|December 2, 2010
Emerging small molecule and biological therapeutic approaches for the treatment of autoimmunityAndrew J Leishman, Gary P Sims, Matthew Sleeman, et al.Immunotherapy|March 15, 2018
Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development programReynold A Panettieri, Millie Wang, Martin Braddock, et al.Drug Safety|February 8, 2018
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic ReviewMartin Braddock, Nicola A Hanania, Amir Sharafkhaneh, et al.Expert Review of Gastroenterology & Hepatology|July 18, 2015
Autophagy in ethanol-exposed liver diseaseLi-Ren Wang, Gui-Qi Zhu, Ke-Qing Shi, et al.Pageof 8